助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   transdermal fentanyl 在 临床医学 分类中 的翻译结果: 查询用时:0.008秒
图标索引 在分类学科中查询
所有学科
临床医学
肿瘤学
外科学
感染性疾病及传染病
皮肤病与性病
心血管系统疾病
更多类别查询

图标索引 历史查询
 

transdermal fentanyl
相关语句
  “transdermal fentanyl”译为未确定词的双语例句
    Clinical observation of Transdermal Fentanyl in the treatment of advanced cancer pain
    芬太尼贴剂治疗73例晚期癌痛的观察和护理
短句来源
    Objective:To observe the therapeutic efficiency and side effects of Transdermal Fentanyl (durogesic) on advanced cancer pain, and the nursing measures.
    目的:观察芬太尼(多瑞吉)贴剂对晚期癌痛的疗效和不良反应,探讨临床护理干预措施。
短句来源
查询“transdermal fentanyl”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  transdermal fentanyl
Pain Recurrence on the Third Day after Application of a Transdermal Fentanyl Patch
      
Neurophysiologic disorders developed in three patients after discontinuation of transdermal fentanyl (TDF) at a daily dose of 0.6?mg (2.5?mg per a patch), although direct removal of a 2.5?mg patch is permitted by the manufacturer as the
      
Withdrawal symptom after discontinuation of transdermal fentanyl at a daily dose of 0.6 mg
      
Transdermal fentanyl treatment in opioid-na?ve cancer patients
      
Transdermal fentanyl seems to be a good palliative measure to treat CNH in patients who have advanced neoplasms.
      
更多          


Objective To evaluate the effect of dosage titration of transdermal fentanyl(Durogesic)using morphine at patient-controlled intravenous analgesia(PCIA) in the treatment of chronic noncancer pain.Methods Twenty three patients with chronic moderate to severe noncancer pain were studied.Before PCIA,pain was assessed by visual analog score(VAS).The patients were received loading dosages(1-2 mg per 5 min)until pain VAS less than 3 scores.Then morphine 0.5 mg/kg was continuously infused as background dose.PCA...

Objective To evaluate the effect of dosage titration of transdermal fentanyl(Durogesic)using morphine at patient-controlled intravenous analgesia(PCIA) in the treatment of chronic noncancer pain.Methods Twenty three patients with chronic moderate to severe noncancer pain were studied.Before PCIA,pain was assessed by visual analog score(VAS).The patients were received loading dosages(1-2 mg per 5 min)until pain VAS less than 3 scores.Then morphine 0.5 mg/kg was continuously infused as background dose.PCA included a bolus dose of morphine 1-2 mg and 10 min lockout time.According to 24 hours dose of intravenous morphine,dosage of durogesic was calculated.In the four time courses,before morphine PCIA,morphine PCIA,durogesic 12 hours with morphine PCIA-Bolus and durogesic 24 to 72 hours,pain VAS and the side effect were assessed. Results The pain was quickly relieved(VAS<3 scores)within 10 to 30 mins.It was sufficiently and effectively maintained for 72 hours.The main side effects included was nausea, vomit,dizziness,sweating and somnolence.The ratio of side effect decreased stepwise following durogesic used.Conclusion Dosage titration of durogesic using PCIA of morphine provides an effective,rapid and individual treatment for moderate to severe chronic noncancer pain.

目的 探讨在慢性非癌性疼痛患者用吗啡病人自控镇痛 (PCA)滴定芬太尼透皮贴剂(多瑞吉 )剂量的可能性。方法 疼痛门诊中到重度慢性非癌性疼痛患者 2 3例 ,采用开放非对照试验使用吗啡静脉PCA行多瑞吉剂量滴定治疗慢性非癌性疼痛。PCA负荷量为每隔 5分钟静注吗啡 1~ 2mg至患者视觉模拟评分 (VAS)小于 3分 ,背景量为 0 5mg/h ,冲击量为 1~ 2mg ,锁定时间 10min ,总量无限定。记录 2 4h静脉吗啡用量 ,换算成多瑞吉贴剂。使用多瑞吉后 ,保留PCA的冲击量 12h再停药。观察并记录吗啡静脉PCA前、PCA中、PCA Bolus +多瑞吉 (12h)和多瑞吉 2 4~ 72h患者的疼痛强度和不良反应。结果 本文所有患者均在 10~ 30min获得良好镇痛 (VAS小于 3分 )并能充分有效维持 72h。观察期间常见不良反应为呕心、呕吐和头晕 ,转换为多瑞吉后不良反应逐渐下降减少。结论 采用吗啡静脉PCA滴定 ,可以快速有效镇痛 ,使多瑞吉应用剂量迅速个体化

Objective:To research the feasibility,efficacy and method of transdermal fentanyl patch(TDF) in the treatment of postoperative pain.Methods:60 women were divided into 3 groups.All patients received TDF 5?mg.Group T and TM received abdominal hysterectomy and epidural anesthesia.Group TM received morphine 1.5~2?mg besides.Group TG received breast cancer resection and general anesthesia.The changes of plasma β-endorphin,serum prolactin and cortisol before and after patch application were analyzed.Heart rate,respiratory...

Objective:To research the feasibility,efficacy and method of transdermal fentanyl patch(TDF) in the treatment of postoperative pain.Methods:60 women were divided into 3 groups.All patients received TDF 5?mg.Group T and TM received abdominal hysterectomy and epidural anesthesia.Group TM received morphine 1.5~2?mg besides.Group TG received breast cancer resection and general anesthesia.The changes of plasma β-endorphin,serum prolactin and cortisol before and after patch application were analyzed.Heart rate,respiratory rate,SpO_2,blood pressure,pain score(VAS),and adverse reactions were monitored at prescribed intervals.Results:VAS pain score was higher in group T at first 24?h after patch application,and gradually down at 24 h after patch application.The analgesia effect was better in group TM than in group T,but more respiratory depression may occur.Group TG and TM had similar analgesia.The concentrations of stress hormone were significantly higher in group T at 24?h after patch application.There was no significant difference in the incidence of adverse effects in all 3 groups.Conclusion:Breast cancer resection can apply TDF 5?mg for postoperative analgesia alone.The analgesia effect was good and safe. If TDF 5 mg is used for hysterectomy postoperative analgesia,the patients need to be assisted by other analgesics until plasma fentanyl concentration reaches a peak level,thereby the analgesia effect can be better.

目的:探讨芬太尼透皮贴剂(TDF)用于术后镇痛的可行性、优越性及具体实施方案.方法:60例患者分为3组.均于麻醉前贴TDF 5 mg.T、TM组为硬膜外麻醉下子宫手术,TM组另加椎管内吗啡1.5~2 mg;TG组为全麻乳房手术.比较使用TDF前后血浆β-内啡肽、血清泌乳素和皮质醇浓度的变化,并监测HR、RR、SpO2、BP、VAS评分以及副作用的发生.结果:T组的VAS评分在24 h内偏高,24 h后逐渐下降;TM组镇痛效果比T组好,有轻度呼吸抑制;TG组镇痛效果与TM组相似;T组应用TDF 24 h后应激激素浓度升高显著;3组患者副作用的发生无显著性差异.结论:全麻下行乳癌根治术应用TDF 5 mg术后镇痛效果好,未发现严重不良反应.硬膜外麻醉下行子宫切除术应用TDF 5 mg需辅用其它镇痛药以弥补TDF起效缓慢的不足,从而获得良好镇痛效果.

Objective: To observe the analgesic efficacy of Transdermal fentanyl (TDF) in patients with chronic and stubborn pain. Methods: Four-hundred and sixteen cases of the ambulatory clinic were enrolled in this study on treatment with TDF, of which 314 were suffering from medial or late cancer pain and 102 were of non-cancerous pain. The intensity of pain (measured by visual analogue scale, VAS), quality of life, side effect of TDF before and after treatment were observed and compared. Results: VAS decreased...

Objective: To observe the analgesic efficacy of Transdermal fentanyl (TDF) in patients with chronic and stubborn pain. Methods: Four-hundred and sixteen cases of the ambulatory clinic were enrolled in this study on treatment with TDF, of which 314 were suffering from medial or late cancer pain and 102 were of non-cancerous pain. The intensity of pain (measured by visual analogue scale, VAS), quality of life, side effect of TDF before and after treatment were observed and compared. Results: VAS decreased significantly from 7.94±1.15 to 1.64±1.71 after treatment in patients with cancerous-pain, and from 7.30±1.54 to 1.91±1.53 in non-cancer patient. In cancer patients, 51.5% was markedly relieved from pain, of 19.7% was free from pain, and total relief rate accounted for 71.2%. In non-cancer patients reached 45%, 13.7%, and 58.7% respectively. The quality of life in both patients improved significantly (P<0.01). The side-effect of TDF was similar to other opiates: mainly dizziness, nausea and vomiting, but they were mild. No occurrence of respiratory depression, physical or mind dependence after stopping treatment. Conclusion: TDF possesses characteristics of noninvasive route of administration, continued release of the drug, valid analgesic effect, mild side-effect, good compliance of patients and is suitable for application in out-patients clinic or family.

目的:观察门诊慢性疼痛患者用芬太尼透皮贴剂(Transdermalfentanyl,TDF)的镇痛疗效。方法:选择慢性顽固性疼痛患者416例,其中中、晚期癌症性疼痛占314例,非癌性疼痛102例,使用TDF止痛。对治疗前后的疼痛强度、生活质量评价及用药中的不良反应,进行观察和统计分析。结果:癌性疼痛治疗前疼痛视觉模拟评分(VAS)为7.94±1.15,治疗后降低至1.64±1.71;非癌性疼痛治疗前为7.30±1.54,治疗后降低至1.91±1.53。癌性疼痛的明显缓解率为51.5%,完全缓解为19.7%,总缓解率71.2%。非癌性疼痛明显缓解率为45.0%,完全缓解13.7%,总缓解率58.7%。生活质量治疗前后均变化(P<0.01)。用药的不良反应与传统的阿片类药物相似,为便秘、恶心、呕吐、头晕等症,但程度较轻;未出现呼吸抑制者。治疗后需停药的患者无身体及精神戒断症状发生。结论:TDF具有无创性、不间断的给药途径,镇痛效果确实,不良反应发生率低,患者依从性好,适合门诊、家庭应用。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关transdermal fentanyl的内容
在知识搜索中查有关transdermal fentanyl的内容
在数字搜索中查有关transdermal fentanyl的内容
在概念知识元中查有关transdermal fentanyl的内容
在学术趋势中查有关transdermal fentanyl的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社